安杰思收盘上涨5.13%，滚动市盈率20.70倍，总市值61.45亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Anjiasi Medical Technology Co., Ltd., which has a closing price of 75.88 yuan, up 5.13%, with a rolling PE ratio of 20.70, marking a new low in 267 days, and a total market capitalization of 6.145 billion yuan [1] - The company operates in the medical device industry, specifically focusing on the research, production, and sales of minimally invasive diagnostic and therapeutic instruments, with key products including GI, EMR/ESD, and ERCP diagnostic series [1] - As of the first quarter of 2025, four institutions hold shares in Anjiasi, with a total of 87,500 shares valued at 0.06 million yuan [1] Group 2 - The average PE ratio for the medical device industry is 54.56, with a median of 37.54, positioning Anjiasi at the 45th rank within the industry [2] - The latest financial results for the first quarter of 2025 show Anjiasi achieved a revenue of 129 million yuan, a year-on-year increase of 15.27%, and a net profit of 56.248 million yuan, reflecting a year-on-year growth of 6.57%, with a gross profit margin of 70.68% [1]